Zhenyu Ding

9PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial.

|Dec 29, 2025
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial.

Naihui Chu, Wenjuan Nie, Juan Du

|Nov 29, 2024
A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice.

Qing Li, Hao Zeng, Ting Liu

|Mar 24, 2022
Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer.

Ye Hong, Ping Duan, Lang He

|Feb 25, 2022
Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer.

Yue Zheng, Yang Fu, Pei-Pei Wang

|Oct 29, 2021
Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.

Peipei Wang, Yueyun Chen, Yue Zheng

Pageof 2

Frequent Collaborators

5 joint publications

Peipei Wang

2 joint publications

Yue Zheng

1 joint publications

Yang Fu

1 joint publications

Yong Wu